On Thursday, Sangamo Biosciences, Inc. (NASDAQ:SGMO)’s shares declined -17.86% to $7.59.
Sangamo BioSciences, Inc. (SGMO) stated its second quarter 2015 financial results and accomplishments.
For the second quarter ended June 30, 2015, Sangamo stated a merged net loss of $12.1 million, or $0.17 per share, contrast to a net loss of $7.0 million, or $0.10 per share, for the same period in 2014. As of June 30, 2015, the Company had cash, cash equivalents, marketable securities and interest receivable of $218.6 million.
Revenues for the second quarter of 2015 were $8.4 million, contrast to $10.4 million for the same period in 2014. Second quarter 2015 revenues were generated from the Company’s partnership agreements with Shire International GmbH (Shire), Biogen Inc. (Biogen), enabling technology agreements and research grants. The revenues recognized for the second quarter of 2015 comprised of $7.8 million in partnership agreements and $0.6 million in research grants, contrast to $9.7 million and $0.7 million, respectively, for the same period in 2014.
Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focused on the research, development, and commercialization of engineered DNA-binding proteins as novel therapeutic products for various monogenic and infectious diseases with unmet medical needs.
ARM Holdings plc (ADR) (NASDAQ:ARMH)’s shares dropped -0.38% to $44.28.
ARM Holdings plc (ADR) (ARMH) has signed an expansive long-term graphics technology agreement with Samsung to enable the creation of next generation devices capable of delivering even more compelling visual experiences. The subscription license covers ARM® Mali™ graphics processing units (GPUs) counting the Mali-T820/830/860, the recently declared Mali-T880 and all future Mali GPUs.
This long term contract with ARM allows Samsung to continue creating innovative products addressing a range of price and performance points to meet the evolving needs of multiple markets. Samsung is already utilizing ARM Mali technology in SoCs powering an impressive range of leading consumer products.
ARM Holdings plc, together with its auxiliaries, designs microprocessors, physical intellectual property (IP), and related technology and software. The company also sells development tools that enhance the performance of embedded applications. Its products comprise microprocessor cores that comprise of specific functions, such as video, graphics, and display technology IP; and physical IP components for the design and manufacture of integrated circuits, which comprise embedded memory, standard cell, and input/output components.
At the end of Thursday’s trade, Tribune Media Co (NYSE:TRCO)‘s shares dipped -4.84% to $44.98.
Tribune Media Company (TRCO) declared that its Chief Financial Officer, Steven Berns, has resigned effective August 11, 2015, to accept the position of CFO at another public company. Tribune Media has designated Chandler Bigelow, its current Chief Strategies & Operations Officer as interim CFO, effective August 12, 2015. The company has initiated an external search for a full time successor as CFO.
Bigelow formerly served as CFO from 2008 to 2013, and is a 17-year veteran of the company. He will continue to serve in his current role.
Berns will remain accessible to Tribune Media to facilitate a smooth transition of duties, and his resignation does not reflect any dispute or disagreement with the company.
Tribune Media Company, through its auxiliaries, operates as a media and entertainment company in the United States. The company operates through two segments, Television and Entertainment, and Digital and Data. The Television and Entertainment segment provides news, entertainment, and sports programming through Tribune Broadcasting local television stations, counting FOX television associates, CW television associates, CBS television associates, ABC television associates, NBC television associates, and independent television stations; and television series and movies on WGN America, a national general entertainment network.
XL Group plc (NYSE:XL), ended its Thursday’s trading session with -0.03% loss, and closed at $38.85.
XL Group plc (XL) stated its second quarter results.
- Operating net income of $245.8 million for the quarter reduced contrast to operating net income of $279.6 million in the preceding year quarter. The current quarter comprises about $27.8 million in integration costs in addition to $59.9 million in catastrophe losses contrast to $34.6 million in catastrophe losses in the preceding year quarter. In addition, the preceding year quarter benefited from the recognition of $28.7 million of profit associated with the commutation of a structured product transaction.
- Net income (loss) attributable to ordinary shareholders of $915.0 million for the quarter raised contrast to a loss of $279.3 million in the preceding year quarter. The current year comprises a $340.4 million gain on the sale of our interest in an operating associate in addition to a $239.2 million favorable impact from the life retrocession derivative, which is offset by a decrease in accumulated comprehensive income and therefore does not impact book value. Additionally, the preceding year comprised of a $621.3 million after tax loss on the sale of our life reinsurance partner.
- Net investment income for the quarter was $223.2 million, contrast to $232.8 million in the preceding year quarter and $208.5 million in the first quarter of 2015. The overall year over year decline is primarily due to the Life Funds Withheld Assets, together with the impact of lower reinvestment yields, partially offset by the addition of two months of investment income on the legacy Catlin portfolio.
XL GROUP Public Limited Company, an insurance and reinsurance company, provides property, casualty, and specialty products to industrial, commercial, and professional firms; and insurance companies and other enterprises worldwide. The company operates in two segments: Insurance and Reinsurance. The Insurance segment offers property, primary and excess casualty, environmental liability, excess and surplus lines, construction, and surety insurance products, in addition to property and casualty programs.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
